Ajovy is a prescription drug that is used to prevent migraine headaches. It was approved by the U.S. Food and Drug Administration (FDA) in 2018 and is now widely used by people suffering from chronic migraine. While Ajovy has proven to be an effective treatment for some patients, it is important to understand the potential side effects associated with the drug in order to ensure its safe and effective use. This article will explore the potential side effects of Ajovy and how they can be managed.
Ajovy is a medication that is used to prevent migraine headaches. It is a monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) receptors on the surface of nerve cells in the brain. By blocking the action of CGRP, Ajovy is able to reduce the frequency and intensity of migraine headaches. Ajovy is administered as an injection once every four weeks and is available in both an auto-injector and a prefilled syringe.
Like all medications, Ajovy can cause side effects. The most common side effects of Ajovy are injection site reactions, such as redness, itching, pain, swelling, and irritation. Other common side effects include nausea, fatigue, and upper respiratory tract infections. In rare cases, Ajovy can cause serious side effects. These include anaphylaxis, a severe allergic reaction that can cause difficulty breathing, hives, and swelling of the face, lips, tongue, and throat. It is important to seek medical attention immediately if any of these symptoms occur. Ajovy can also cause liver damage, which can lead to jaundice, dark urine, and abdominal pain. It is important to speak to a doctor if any of these symptoms occur. Additionally, Ajovy can cause an increase in blood pressure, which can lead to dizziness, headaches, and blurred vision.
The side effects of Ajovy can be managed with proper monitoring and treatment. It is important to speak to a doctor if any side effects occur, as they may be able to adjust the dosage or switch to a different medication. Additionally, it is important to monitor for any changes in blood pressure, as this can be an indication of an increase in blood pressure. It is also important to stay hydrated and get plenty of rest. Additionally, it is important to avoid alcohol and other substances that can increase the risk of side effects.
Ajovy is an effective medication for preventing migraine headaches, but it is important to understand the potential side effects associated with the drug. Common side effects include injection site reactions, nausea, fatigue, and upper respiratory tract infections. In rare cases, Ajovy can cause serious side effects, such as anaphylaxis, liver damage, and increased blood pressure. It is important to speak to a doctor if any side effects occur, as they may be able to adjust the dosage or switch to a different medication. Additionally, it is important to stay hydrated and get plenty of rest, as well as avoid alcohol and other substances that can increase the risk of side effects.
1.
Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.
2.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
3.
GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer
4.
Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.
5.
In Acute Leukemia With Heavily Pretreated Patients, Menin Inhibitor Yields 63 Percent ORR.
1.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
2.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
3.
Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions
4.
Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management
5.
Fc Receptor Mediated Pharmacology of Therapeutic Antibodies
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
2.
Oropharyngeal Cancer in Relation to HPV Status
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation